← Back to screener

Medpace Holdings, Inc. MEDP

Rank #1550 · Nasdaq · $18.6B market cap
Audited by Deloitte & Touche LLP, no going-concern flag in the latest filing.
Score
46.4
P/E
65.8
P/B
48.19
ROE
73.2%
Op. Margin
17.9%
Debt Ratio
330%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Weak

P/E 65.8x, P/B 48.19x. Ranks in the top 74% of the universe.

Profitability ★★★★☆
Excellent

ROE 73.2%. Ranks in the top 14% of the universe.

Safety ★☆☆☆☆
Weak

Debt ratio 330%. Ranks in the top 74% of the universe. Above 200% signals meaningful leverage risk.

Growth ★★★★☆
Excellent

Revenue growth of 29.2% year over year. Ranks in the top 12% of the universe.

Profitability is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2016–$0.0B$-0.0B$0.4B–138
2017–$0.0B$-0.0B$0.4B–92
2018$0.4B$0.1B$0.0B$0.4B12.5108
2019$0.4B$0.1B$0.0B$0.6B14.962
2020$0.7B$0.1B$0.1B$0.5B14.380
2021$0.9B$0.1B$0.1B$0.6B14.868
2022$0.9B$0.2B$0.1B$0.7B18.097
2023$1.1B$0.2B$0.2B$0.8B17.4120
2024$1.5B$0.3B$0.2B$1.0B19.1115
2025$1.9B$0.3B$0.3B$0.4B17.9330

← See the full screener